INTEGRATED BIOPHARMA (INBP) director receives 50,000 stock options at $0.19

Rhea-AI Filing Summary

INTEGRATED BIOPHARMA director Eric J. Friedman received a grant of stock options for 50,000 shares of common stock. The options have an exercise price of $0.19 per share and expire on June 24, 2036. They vest in four equal installments of 12,500 options on September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027, giving him rights to purchase up to 50,000 shares once vested.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Friedman Eric J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	50,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 50,000 options Exercise price: $0.19 per share Options after transaction: 50,000 derivative securities +3 more

6 metrics

Option grant size 50,000 options Stock Option (Right to Buy) granted to director

Exercise price $0.19 per share Conversion or exercise price of stock options

Options after transaction 50,000 derivative securities Total options following transaction

Expiration date June 24, 2036 Option expiration for entire grant

First vesting tranche 12,500 options Vesting on September 30, 2026

Subsequent vesting tranches 12,500 options each date Vesting on Dec 31 2026, Mar 31 2027, Jun 30 2027

Key Terms

Stock Option (Right to Buy), exercise price, vest and become exercisable, Common Stock

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "0.1900" per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest and become exercisable financial

"The stock options vest and become exercisable in four equal installments"

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 12:15 PM Accepted by SEC EDGAR 06/25/2026 - 12:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Friedman Eric J

(Last) (First) (Middle)

C/O INTEGRATED BIOPHARMA, INC.

225 LONG AVENUE, BLDG 15

(Street)

HILLSIDE NEW JERSEY 07205

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRATED BIOPHARMA INC [ INBP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/24/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.19	06/24/2026		A		50,000		(1)	06/24/2036	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.

Remarks:

This Amendment corrects Box 9 - Number of Derivative Securities Beneficially Owned Following Reported Transaction from 50 to 50,000.

	/s/ Eric Friedman	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did INTEGRATED BIOPHARMA (INBP) report for Eric J. Friedman?

INTEGRATED BIOPHARMA reported that director Eric J. Friedman received a grant of stock options for 50,000 shares of common stock. These options allow him to buy shares at a fixed price once vested, reflecting equity-based compensation rather than an open-market purchase or sale.

How many INBP shares are covered by Eric J. Friedman’s new stock options?

The grant covers stock options on 50,000 shares of INTEGRATED BIOPHARMA common stock. Each option represents the right to buy one share, so the award provides potential future ownership of up to 50,000 shares if all options vest and are exercised.

What is the exercise price of Eric J. Friedman’s INBP stock options?

The stock options granted to Eric J. Friedman have an exercise price of $0.19 per share. This means he can buy INTEGRATED BIOPHARMA common stock at $0.19 for each option, once the options vest and before they expire in 2036, regardless of future market prices.

When do Eric J. Friedman’s INBP stock options vest?

The 50,000 INBP stock options vest in four equal installments of 12,500 each. Vesting dates are September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027, gradually giving him exercisable rights over the full award.

When do Eric J. Friedman’s INBP stock options expire?

The stock options granted to Eric J. Friedman expire on June 24, 2036. After this expiration date, any unexercised options become worthless, so he must exercise vested options before then to acquire INTEGRATED BIOPHARMA common shares at the stated exercise price.

Is Eric J. Friedman’s INBP Form 4/A transaction a market buy or sell?

The Form 4/A shows a grant of derivative securities, not a market trade. Eric J. Friedman acquired 50,000 stock options as a compensation award, coded as an “A” transaction, rather than buying or selling INTEGRATED BIOPHARMA shares on the open market.